Infant ≥2 months to children <12 years: 10mg/kg/day (maximum 200mg/dose) q 12 h
Children >12 years to adolescent: 100 to 400mg q 12 h
Bronchitis (chronic), acute bacterial infection
Adult dosing for Infant ≥2 months to children <12 years
Acute otitis media
Infant ≥2 months to children <12 years: 5mg/kg/dose (maximum 200mg/dose) q 12 h for 5 days, duration according to AAP recommendation : for children < 2 years or any age with sever symptoms; 10 day-course, age 2-**5 years with mild to moderate symptoms: 7 day-course; age ≥ 6 years with mild to moderate symptoms: 5 day-course
Pharyngitis/tonsillitis:
Infant ≥2 months to children <12 years: 5mg/kg/dose (maximum 100mg/dose) q 12 h for 5-10 days
Children >12 years to adolescent: adult dosing
Acute sinusitis
Infant ≥2 months to children <12 years: 5mg/kg/dose (maximum 200mg/dose) q 12 h for 10 days, ISDA recommend adding Clindamycin for 10-14 days in patients with failed initial therapy or at risk of antibiotic resistance (attending daycare, age <2 years, recently hospitalised, antibiotic used with in 1 month) 
Children >12 years to adolescent: adult dosing
Skin soft tissue infection and uncomplicated urinary tract infection
Children >12 years to adolescent: adult dosing
Adult dosing for Infant ≥2 months to children <12 years
Infant ≥2 months to children <12 years: 5mg/kg/dose (maximum 200mg/dose) q 12 h for 5 days, duration according to AAP recommendation : for children < 2 years or any age with sever symptoms; 10 day-course, age 2-**5 years with mild to moderate symptoms: 7 day-course; age ≥ 6 years with mild to moderate symptoms: 5 day-course
Infant ≥2 months to children <12 years: 5mg/kg/dose (maximum 100mg/dose) q 12 h for 5-10 days
Children >12 years to adolescent: adult dosing
Infant ≥2 months to children <12 years: 5mg/kg/dose (maximum 200mg/dose) q 12 h for 10 days, ISDA recommend adding Clindamycin for 10-14 days in patients with failed initial therapy or at risk of antibiotic resistance (attending daycare, age <2 years, recently hospitalised, antibiotic used with in 1 month) 
Children >12 years to adolescent: adult dosing
Children >12 years to adolescent: adult dosing
Cefpodoxime
Fomepizole
Pralidoxime
Physostigmine
Cefizoxime
N-Acetylcysteine
Pyridostigmine
Neostigmine